Researchers have developed an innovative PET tracer targeting the protein nectin-4, commonly overexpressed in triple-negative breast cancer and urothelial bladder carcinoma. This new tracer permits rapid same-day immuno-PET imaging, significantly enhancing clinical visualization of these aggressive cancers. This technology may improve early detection, treatment planning, and patient outcomes in these challenging oncologic indications.